authors
- Sridhar, SS
- Canil, CM
- Hotte, Sebastien
- Chi, KN
- Ernst, S
- Pond, Gregory
- Dick, C
- Zwiebel, JA
- Moore, MJ
A phase 2 study of GTI-2040 plus docetaxel and prednisone as 1st line treatment in hormone-refractory prostate cancer (HRPC).
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- December 15, 2005
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Clinical Cancer Research Journal